stockrowUnited Therapeutics Corporation
UTHR Healthcare Drug Manufacturers Specialty & Generic
United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.
- Revenue
- +4.13%
- EPS
- −21.7%
- Free cash flow
- −63.7%
Quarter to September 2026, against a year earlier
Follow UTHR
Alert me
United Therapeutics Corporation (UTHR) Net income
United Therapeutics Corporation's net income for fiscal 2025 was $1.3B, up 11.7% from $1.2B in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.2B. Over the past ten years it has ranged from −$104.5M (fiscal 2019) to $1.3B (fiscal 2025) — the current reading is the highest in ten years. Net income has risen for 4 consecutive fiscal years. United Therapeutics Corporation ranks 4th of 84 Drug Manufacturers Specialty & Generic companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $1.3B | 11.68% |
| FY2024 | $1.2B | 21.35% |
| FY2023 | $984.8M | 35.40% |
| FY2022 | $727.3M | 52.86% |
| FY2021 | $475.8M | (7.58%) |
| FY2020 | $514.8M | — |
| FY2019 | −$104.5M | — |
| FY2018 | $589.2M | 40.99% |
| FY2017 | $417.9M | (41.45%) |
| FY2016 | $713.7M | 9.53% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $333.0M | 21.13% |
| Mar 2026 | $274.9M | (24.54%) |
| Dec 2025 | $364.3M | 7.56% |
| Sep 2025 | $338.7M | 9.43% |
| 42 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| TAK Takeda Pharmaceutical Co. compare | $3.2B |
| HLN Haleon PLC Sponsored ADR compare | $3.1B |
| ZTS Zoetis Inc. compare | $2.6B |
| UTHR United Therapeutics Corporation | $1.2B |
| NBIX Neurocrine Biosciences, Inc. compare | $702.5M |
| TEVA Teva Pharmaceutical Industries Ltd. compare | $508.0M |
| RDY Dr. Reddy's Laboratories Ltd compare | $273.0M |
| ELAN Elanco Animal Health Incorporated compare | −$199.0M |
| VTRS Viatris Inc. compare | −$607.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on UTHR
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement